KKR & Co Inc is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows positive momentum in hedge fund activity, strong congressional buying, and promising growth prospects in the aviation and healthcare sectors. While technical indicators are neutral, the overall sentiment and long-term potential make it a solid choice.
The MACD histogram is positive at 0.528, indicating bullish momentum, though it is contracting. RSI is neutral at 54.994, and moving averages are converging, suggesting no strong directional trend. Key levels are Pivot: 96.278, R1: 99.827, S1: 92.729.

Hedge funds are significantly increasing their positions, with a 604.51% rise in buying activity.
Congress members made two recent purchase transactions, showing confidence in the stock.
KKR's $1.4 billion investment in aircraft leasing and advanced talks to acquire Medicover's Indian operations for $1 billion indicate strategic growth in key sectors.
Analysts maintain strong price targets, with UBS at $126 and Oppenheimer at $143.
Analysts have mixed views, with some lowering price targets due to concerns over earnings quality and private credit transparency.
Technical indicators do not show a clear bullish signal, which may indicate short-term price stagnation.
No financial data available for the latest quarter.
Analysts have mixed ratings, with UBS and Oppenheimer maintaining Buy and Outperform ratings, while TD Cowen and RBC Capital have Hold ratings. Price targets range from $102 to $143, reflecting optimism in the long-term growth potential but caution over near-term earnings quality.